Installing cameras in pharmaceutical Grade A/B areas supports regulatory expectations for continuous oversight, contamination control, and traceability. While not explicitly mandated by FDA/EMA, regulators expect facilities to ensure effective remote observation of critical aseptic operations. If cameras are not used, the site must demonstrate equally robust alternatives—such as observation windows, enhanced monitoring, and strong procedural controls—to avoid potential non‑compliance during inspections.

Price: 2 Euros